BioSig Technologies (NASDAQ:BSGM) Posts Earnings Results, Misses Estimates By $0.09 EPS

BioSig Technologies (NASDAQ:BSGM) released its quarterly earnings data on Monday. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.09), Zacks reports.

BioSig Technologies Trading Up 7.4%

BSGM stock traded up $0.21 during trading on Tuesday, hitting $3.06. 419,087 shares of the stock traded hands, compared to its average volume of 264,020. BioSig Technologies has a one year low of $0.20 and a one year high of $3.18. The company has a 50 day simple moving average of $0.99 and a 200 day simple moving average of $1.20.

Analysts Set New Price Targets

Separately, Ascendiant Capital Markets reduced their price objective on shares of BioSig Technologies from $2.75 to $2.50 and set a “buy” rating for the company in a report on Monday, April 21st.

BioSig Technologies Company Profile

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.